TABLE 3.
The Hardy–Weinberg equilibrium significance tests of the nine miRNA SNPs selected in the current study.
| SNPs | Genotypes n (%) | HWE (p-value) | ||
|---|---|---|---|---|
| rs107822 | T/T | T/C | C/C | |
| Control | 275 (39.4) | 314 (45.0) | 109 (15.6) | 0.221 |
| CIN | 101 (37.0) | 124 (45.4) | 48 (17.6) | 0.355 |
| CC | 139 (32.3) | 202 (46.9) | 90 (20.9) | 0.296 |
| rs10877887 | T/T | T/C | C/C | |
| Control | 286 (41.0) | 335 (48.0) | 77 (11.0) | 0.150 |
| CIN | 126 (46.2) | 123 (45.1) | 24 (8.8) | 0.435 |
| CC | 185 (42.9) | 200 (46.4) | 46 (10.7) | 0.457 |
| rs2292832 | T/T | T/C | C/C | |
| Control | 293 (42.0) | 316 (45.3) | 89 (12.8) | 0.792 |
| CIN | 114 (41.8) | 132 (48.4) | 27 (9.9) | 0.207 |
| CC | 209 (48.5) | 189 (43.9) | 33 (7.7) | 0.275 |
| rs353293 | C/C | C/T | T/T | |
| Control | 499 (71.5) | 180 (25.8) | 19 (2.7) | 0.570 |
| CIN | 181 (66.3) | 84 (30.8) | 8 (2.9) | 0.640 |
| CC | 322 (74.7) | 100 (23.2) | 9 (2.1) | 0.707 |
| rs3746444 | A/A | A/G | G/G | |
| Control | 490 (70.2) | 183 (26.2) | 25 (3.6) | 0.130 |
| CIN | 184 (67.4) | 75 (27.5) | 14 (5.1) | 0.090 |
| CC | 292 (67.7) | 119 (27.6) | 20 (4.6) | 0.088 |
| rs3803808 | A/A | A/G | G/G | |
| Control | 246 (35.2) | 340 (48.7) | 112 (16.0) | 0.761 |
| CIN | 83 (30.4) | 134 (49.1) | 56 (20.5) | 0.887 |
| CC | 137 (31.8) | 215 (49.9) | 79 (18.3) | 0.739 |
| rs4078756 | T/T | T/C | C/C | |
| Control | 384 (55.0) | 277 (39.7) | 37 (5.3) | 0.152 |
| CIN | 152 (55.7) | 105 (38.5) | 16 (5.9) | 0.702 |
| CC | 250 (58.0) | 155 (36.0) | 26 (6.0) | 0.762 |
| rs629367 | A/A | A/C | C/C | |
| Control | 407 (58.3) | 250 (35.8) | 41 (5.9) | 0.751 |
| CIN | 176 (64.5) | 82 (30.0) | 15 (5.5) | 0.192 |
| CC | 255 (59.2) | 145 (33.6) | 31 (7.2) | 0.105 |
| rs7372209 | C/C | C/T | T/T | |
| Control | 323 (46.3) | 294 (42.1) | 81 (11.6) | 0.262 |
| CIN | 117 (42.9) | 126 (46.2) | 30 (11.0) | 0.651 |
| CC | 208 (48.3) | 189 (43.9) | 34 (7.9) | 0.321 |